Targeted Probiotics for Targeted Outcomes: A Guide for Healthcare Providers

The probiotic market has experienced remarkable growth in recent years, driven by increasing awareness and research examining the gut microbiome’s role in health. (Liang 2024) As use of these supplements expands, probiotic products have flooded the market, underscoring the need to understand that not all probiotics are created equal.

The benefits of probiotics are strain-dependent, with different strains demonstrating unique mechanisms of action and efficacy in various conditions. (McFarland 2018) As healthcare providers incorporate probiotics into patient care, understanding the scientific foundation behind each strain and its clinically proven applications drives an evidence-based approach to prescribing. This enables personalized, outcome-driven recommendations that maximize therapeutic potential.

Improve patient outcomes while growing your practice

Join 100,000 providers who rely on Fullscript to access top-quality supplements and labs.

Create free account

What Are Probiotics?

Probiotics, defined by the World Health Organization (WHO) and the Food and Agriculture Organization (FAO), are live microorganisms that confer a health benefit to the host when administered in adequate amounts. (FAO/WHO 2002) This definition highlights the criteria for a product to be considered a probiotic: 

• The exact type and strain of the microorganism must be identified.
• It should not cause harm when taken as directed.
• Reliable evidence from at least one well-designed human study shows it provides a real health benefit.
• It must contain enough live microorganisms in a therapeutic dose throughout its shelf life. (Binda 2020)

Common probiotic strains include species of Lactobacillus, Bifidobacterium, and Saccharomyces. (NIH 2025)

The concept of utilizing beneficial microbes to support health is not a new one. It dates back over a century to the work of Élie Metchnikoff, who hypothesized that consuming fermented dairy products containing live bacteria could promote longevity and improve digestive health. (Gasbarrini 2016)

Probiotics have since evolved from being viewed solely as digestive aids to being recognized as potential therapeutic tools in various health contexts, such as immune function, metabolism, mental health, allergies, oral health, and cardiovascular disease. (de Vrese 2008)(Bodke 2022)

Prebiotics vs. Probiotics vs. Postbiotics

Building on the understanding of probiotics, it is equally important to differentiate them from related but distinct concepts within the field of biotics.

Prebiotics

Prebiotics are parts of food, usually certain fibers, that the body can’t digest. They help good bacteria in the gut grow and stay active, conferring health benefits to the host. You can think of prebiotics as food for the helpful microbes living in the digestive tract. Unlike probiotics, prebiotics don’t have any live bacteria themselves. Instead, they provide the nutrients that support probiotics and other friendly bacteria already in your gut. (Davani-Davari 2019)

A compound must meet the following criteria to be classified as a prebiotic:

• It is resistant to stomach acid and cannot be degraded by digestive enzymes or absorbed in the gastrointestinal (GI) tract.
• The intestinal microbiota can ferment it.
• It can stimulate the growth and activity of intestinal bacteria, positively impacting human health. (Davani-Davari 2019)

Inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS) have long been accepted as established prebiotic ingredients. Other compounds with demonstrated prebiotic effects include:

• Arabinooligosaccharides
• Beta-glucan
• Oligofructose
• Isomaltooligosaccharides
• Guar gum
• Lactulose
• Maltodextrin
• Resistant starch
• Xylooligosaccharides (Carlson 2018) 

Prebiotics provide positive health effects by:

• Helping maintain a healthy balance of gut microbes by encouraging the growth of beneficial bacteria like Bifidobacterium and Lactobacillus, while limiting the growth of harmful bacteria (Carlson 2018) 
• Fermenting in the colon to produce short-chain fatty acids (SCFAs), which can acidify the colon, modulate the immune system, and balance levels of intestinal inflammation (Davani-Davari 2019)(Mahdavi 2021)
• Improving mineral absorption (Whisner 2017)

Probiotics

As discussed above, probiotics are the live microorganisms introduced into the gut to provide health benefits. These strains can colonize the gut or interact with resident microbes to restore balance, outcompete pathogens, reinforce the intestinal barrier, and influence immune cell activity. (Hemarajata 2013)

Sources of probiotics include supplements and fermented foods/drinks. Examples include: 

• Kombucha
• Sauerkraut
• Kimchi
• Kefir
• Natto
• Miso
• Tempeh
• Yogurt (Rezac 2018)(Dimidi 2019) 

Synbiotics combine probiotics with prebiotics to enhance the survival, growth, and activity of the beneficial microorganisms. (Pandey 2015)

Postbiotics

Postbiotics, as defined by the International Scientific Association for Probiotics and Prebiotics (ISAPP), are “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host.” (Vinderola 2022)

Postbiotics are non-living and distinct from probiotics and prebiotics. However, their production depends on the metabolic activity of live microbes—whether probiotic strains or resident gut bacteria—often involving the fermentation of prebiotic fibers. (Vinderola 2022)(Wegh 2019)

Unlike probiotics, postbiotics do not contain live microorganisms. Examples include:

• SCFAs
• Extracellular polysaccharides
• Enzymes
• Cell wall fragments
• Peptides
• Vitamins (Żółkiewicz 2020)(Thorakkattu 2022)

Postbiotics act as signaling molecules that influence gut barrier integrity, immune function, metabolism, and inflammation. (Ma 2023)(Zdybel 2025)

Strain-Specificity Matters

Probiotic effects are fundamentally strain- and disease-specific, meaning that the clinical benefits observed with one strain cannot be assumed for another, even within the same species. (McFarland 2018)

This idea is supported by evidence from studies on Lactobacillus rhamnosus GG (LGG) and L. rhamnosus GR-1.

LGG has been widely studied for its benefits in managing digestive issues. Research shows that it can boost the immune defenses in the gut by helping produce more mucosal immunoglobulin A (IgA), encouraging the release of interferon (a protein important for immune response), and assisting the immune system in recognizing and fighting harmful substances. (Gorbach 2000) A recent review of 69 randomized controlled trials (RCTs) found that taking LGG is linked to a lower risk of diarrhea and shorter illness duration, especially in children. (Hidayat 2025) 

On the other hand, L. rhamnosus GR-1 supports women’s urinary and vaginal health. GR-1 produces certain protein-like substances that may help reduce inflammation caused by infections in the uterine muscles. (Kim 2019) Clinical studies have shown that GR-1 helps balance the vaginal microbiome and supports urinary tract health. (Petrova 2021) For example, in one study, 125 women taking oral probiotics with GR-1 and L. reuteri RC-14 alongside antibiotic treatment had a much higher cure rate after 30 days than those given a placebo (88% vs. 40%, based on Nugent scoring and symptom resolution). (Anukam 2006)

The key takeaway is that it is important to select probiotic strains with clinical evidence supporting their use for specific health outcomes you are aiming to address. Relying on probiotic products without validated strains risks delivering inconsistent results.

Clinical Applications of Probiotics

Below are key areas where probiotics have demonstrated clinical benefits.

Gut Health

Research shows that probiotics can help manage a variety of digestive conditions, ranging from constipation to irritable bowel syndrome (IBS) to ulcerative colitis. (Wilkins 2017) 

Specific applications include:

• Intestinal permeability (“leaky gut”): Butyrate-producing bacteria, such as Anaerostipes species, support tight junction integrity, reduce permeability, and lower inflammation. Low levels have been observed in people with IBS, inflammatory bowel disease, and infections. (Singh 2023)
• Helicobacter pylori (H. pylori) infection: L. reuteri DSM17648 has been shown to reduce bacterial urease activity, improve symptoms of indigestion without causing side effects, and boost treatment tolerability and eradication rates when used alongside standard triple antibiotic therapy. (Buckley 2018)(Ismail 2023) 
• IBS: In a multicenter clinical trial, Bifidobacterium infantis 35624 significantly improved abdominal pain, bloating, bowel dysfunction, and overall symptom scores compared to placebo in 362 women with IBS after four weeks. (Whorwell 2006)
• Antibiotic use: Taking a multi-strain synbiotic during and after antibiotic therapy may help reduce antibiotic-associated side effects by supporting gut barrier integrity and maintaining healthy levels of beneficial bacteria. (Napier 2024)

Immune Health

The GI tract houses a large portion of the body’s immune cells and acts as a barrier against pathogens. The gut microbiome helps shape immune responses by interacting with immune cells, producing SCFAs and other metabolites, and promoting the development of immune tolerance. (Wiertsema 2021)

Probiotic supplementation, therefore, may support positive immune outcomes. For example, a study found that a multi-strain probiotic containing high concentrations of Lactobacillus, Bifidobacterium, and Streptococcus species helped decrease post-viral symptoms (e.g., fatigue, cognitive dysfunction, and inflammation markers). (Marinoni 2023) 

Mental Health

The gut-brain axis (GBA) is the bidirectional communication network between the GI tract and the central nervous system, involving neural, hormonal, and immune pathways. Within this context, psychobiotics are a class of probiotics that can modulate the gut microbiome and its interactions with the brain. (Cheng 2019)

B. longum 1714, for example, has been shown to exert psychobiotic effects in studies. This was demonstrated by altered brain activity and subjective improvements in energy when participants were faced with social stress, lower subjective levels of stress, and reductions in cortisol (the “stress hormone”) output. (Allen 2016)(Wang 2019)

Metabolic Health

Researchers have begun to evaluate the influence of certain probiotics on aspects of metabolic health. Some of these benefits include:

• Producing SCFAs: Butyrate promotes insulin sensitivity, explaining why low butyrate levels may be associated with metabolic syndrome. (Santos-Marcos 2019)(Mayorga-Ramos 2022) Results from a 12-week trial in 58 patients with type 2 diabetes suggest that butyrate and ursodeoxycholic acid (UDCA) produced by Clostridium butyricum support healthy blood sugar levels, leading to reductions in hemoglobin A1c (HbA1c). (McMurdie 2022)
• Supporting hormone production: Studies suggest that Akkermansia muciniphila influences human metabolic responses, particularly glucose and lipid metabolism, possibly by increasing glucagon-like peptide-1 (GLP-1) levels, a hormone involved in insulin secretion and hunger signals. In humans, pasteurized A. municiphila has shown favorable metabolic effects, including improved insulin sensitivity, lower fasting insulin and total cholesterol, and trends toward reduced body weight, in overweight/obese, insulin-resistant adults over three months. (Depommier 2019)

Skin Health

Research shows that the composition of the gut microbiome is associated with skin conditions such as eczema, and that taking probiotics may help rebalance the gut microbiome to support skin health. (Lee 2018) In an RCT of 50 children with eczema, those who took an oral probiotic containing B. lactis CECT 8145, B. longum CECT 7347, and L. casei CECT 9104 for 12 weeks had less severe eczema and required less topical steroid use compared to the placebo group. (Navarro-López 2018) 

Environmental and Toxin Defense

Glyphosate, a widely used herbicide, may disrupt the gut microbiome and contribute to dysbiosis. In an in-vitro gut model, treatment with a spore-based probiotic containing Bacillus indicus HU36, B. clausii (SC-109), B. subtilis HU58, B. licheniformis (SL-307), and B. coagulans (SC-208) reversed some of these metabolic disturbances by normalizing SCFA levels. (Mesnage 2022)

Lung Health

The concept of the gut-lung axis suggests that the composition of the gut microbiome can influence the development and progression of lung disease by modulating systemic immune responses. In patients with asthma and chronic obstructive pulmonary disease (COPD), supplementation with a probiotic blend containing L. plantarum RSB11, L. acidophilus RSB12, and L. rhamnosus RSB13 has been associated with improvements in lung function and quality of life. (Wenger 2023)(Nicola 2024)

Vaginal Health

Evidence supports the use of Lactobacillus-based probiotics—including L. crispatus, L. gasseri, L. rhamnosus, L. jensenii, and L. acidophilus—to support a healthy vaginal environment. Positive clinical outcomes associated with these probiotic species have included:

• Reduction of vaginal bacterial imbalance
• Maintenance of vaginal Lactobacillus dominance
• Decreased incidence of vaginal symptoms
• Increased recovery rates and symptom improvement in bacterial vaginosis (BV)
• Reduction in vaginal Candida colonization, symptom improvement, and lower recurrence of vulvovaginal yeast infections (Hilton 1992)(Anoshina 2017)(Laue 2018)(Mollazadeh-Narestan 2023)

Practical Recommendations for Providers

When incorporating probiotics into patient care, several factors can help optimize their effectiveness to ensure the best possible outcomes. Consider the following to guide your clinical decisions and patient conversations:

• Use targeted probiotic strains supported by published clinical studies for the specific health outcome you are addressing. (McFarland 2018)
• Educate patients that more colony-forming units (CFUs) do not necessarily mean a probiotic will be more effective. (NIH 2025) 
• Consider delivery format, such as enteric-coated, spore-forming, and encapsulated shelf-stable products, to optimize probiotic viability and survivability within the GI tract. (Sniffen 2018)
• Microbiome testing (e.g., stool, vaginal, or oral testing) can be beneficial when a personalized approach is desired. These tests can provide valuable insights to target probiotic selection based on an individual’s unique microbiota makeup and clinical symptoms.

Conclusion

Probiotics are live microorganisms that can lead to specific health benefits when consumed in adequate amounts. They work synergistically with prebiotics and postbiotics to support gut and overall health. Clinical applications of probiotics extend beyond digestive health to include immune support, mental well-being, metabolic regulation, skin conditions, and more. 

Careful selection of probiotics based on scientific evidence, appropriate dosing, and an awareness of delivery methods can help healthcare providers offer personalized and effective recommendations.

Improve patient outcomes while growing your practice

Join 100,000 providers who rely on Fullscript to access top-quality supplements and labs.

Create free account